Jushi HoldingsJUSHF -1.13%47 Days Payable is 57.08 as of Mar. 2026, which is 50% above its 10-year median of 37.98. GuruFocus rates JUSHF with a GF Score™ of 47/100 and a GF Value™ of $0.51 (Fairly Valued). The stock has 5 warning signs investors should review. Among 920 Drug Manufacturers companies, Jushi Holdings ranks worse than 73.48% on this metric.
The historical rank and industry rank for Jushi Holdings's Days Payable or its related term are showing as below:
JUSHF'
s Days Payable Range Over the Past 10 Years
Min: 20.66 Med: 37.98 Max: 54.52
Current: 51.85
During the past 13 years, Jushi Holdings's highest Days Payable was 54.52. The lowest was 20.66. And the median was 37.98.
JUSHF's Days Payable is ranked worse than 73.48% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs JUSHF: 51.85
Jushi Holdings's Days Payable
increased
from Mar. 2025 (50.25) to Mar. 2026 (57.08).
It may suggest that Jushi Holdingsdelayed paying its suppliers.
Jushi Holdings Days Payable Related Terms
Jushi Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Jushi Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jushi Holdings Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Jushi Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Jushi Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jushi Holdings (JUSHF) has a Days Payable of 57.08 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jushi Holdings and its competitors. This is 50% above median its historical median of 37.98. Over the past decade, Jushi Holdings' Days Payable has ranged from 20.66 to 54.52. According to the industry distribution chart, Jushi Holdings ranks #676 out of 920 companies in the Drug Manufacturers industry, placing it in the top 73.5%.
Is Jushi Holdings' Days Payable too high?
Jushi Holdings' current Days Payable of 57.08 is 50% above median its 10-year median of 37.98. Over the past 10 years, this metric has ranged from a low of 20.66 to a high of 54.52. The Drug Manufacturers industry median Days Payable is 90.84. Jushi Holdings' value of 57.08 is 37.2% below this industry median. Based on the distribution chart, Jushi Holdings ranks #676 out of 920 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jushi Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jushi Holdings' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jushi Holdings ranks #676 out of 920 companies for Days Payable. This places Jushi Holdings in the lower half of its industry. The industry median Days Payable is 90.84. Jushi Holdings' value of 57.08 is 37.2% below this benchmark. Historically, Jushi Holdings' own Days Payable has ranged from 20.66 to 54.52 over the past decade. While the company's 10-year median is 37.98 vs. the industry median of 90.84, Jushi Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jushi Holdings's current Days Payable of 57.08 is 37.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jushi Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jushi Holdings's current Days Payable is 57.08, which is 50% above median its own 10-year median of 37.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jushi Holdings stock overvalued right now?
Based on GuruFocus' analysis, Jushi Holdings (JUSHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.51, compared to a current price of $0.48 — trading 6% below its estimated fair value. The current Days Payable is 57.08, which is 50% above median its 10-year median of 37.98 and 37.2% below the Drug Manufacturers industry median of 90.84. Jushi Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jushi Holdings (JUSHF), the current Days Payable is 57.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jushi Holdings (JUSHF) Overvalued in 2026?
Based on GuruFocus' analysis, Jushi Holdings stock appears to be undervalued.
The current stock price of $0.48 is trading 6% below its estimated GF Value™ of $0.51.
GuruFocus considers Jushi Holdings to be Fairly Valued.
Key valuation signals for JUSHF:
Days Payable: 57.08 (50% above median its 10-year median of 37.98)
GF Value™: $0.51 vs. price of $0.48 (6% below fair value)
Industry Position: 37.2% below the Drug Manufacturers median (#676 of 920)
No single metric tells the full story. See the JUSHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature's Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
47GF Score
Get the complete analysis for JUSHF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUSHF has been successfully added to your 
